Pisa, Italy

Emanuela Franchi

This inventor holds 2 USPTO granted patents. Top assignee: The Procter Gamble Company. Active years: 2003-2006.


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2003-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Emanuela Franchi: Innovator in Chromotropic Compounds

Introduction

Emanuela Franchi is a notable inventor based in Pisa, Italy. She has made significant contributions to the field of chemistry, particularly in the development of chromotropic compounds. With a total of 2 patents to her name, her work is recognized for its innovative approach to identifying free radicals.

Latest Patents

Emanuela's latest patents include a groundbreaking radical scavenger, which is a new chromotropic compound. This invention encompasses compositions containing such a compound and methods for utilizing it, particularly in test methods for identifying the presence of free radicals. Her work in this area has the potential to advance research in various scientific fields.

Career Highlights

Emanuela Franchi is currently employed at The Procter & Gamble Company, where she continues to apply her expertise in chemistry. Her role at this prestigious company allows her to collaborate with other talented professionals and contribute to innovative product development.

Collaborations

Emanuela has worked alongside notable colleagues such as Francesca Cicogna and Giovanni Ingrosso. Their collaborative efforts have further enhanced the research and development of new compounds and methodologies.

Conclusion

Emanuela Franchi's contributions to the field of chemistry, particularly through her patents and work at The Procter & Gamble Company, highlight her as a significant figure in innovation. Her research on chromotropic compounds is paving the way for advancements in identifying free radicals, showcasing her impact on science and technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…